论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
列线图预测糖尿病患者90天内再入院:一项前瞻性研究
Authors Dong Z , Xie W, Yang L, Zhang Y, Li J
Received 18 October 2024
Accepted for publication 7 January 2025
Published 17 January 2025 Volume 2025:18 Pages 147—159
DOI https://doi.org/10.2147/DMSO.S501634
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Jae Woong Sull
Ziyan Dong, Wen Xie, Liuqing Yang, Yue Zhang, Jie Li
School of Nursing, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People’s Republic of China
Correspondence: Jie Li, School of Nursing, Tongji Medical College, 13 hangkong Road, Qiaokou District, Wuhan, Hubei Province, 430030, People’s Republic of China, Tel +86-189-7109-7091, Email Lijie@hust.edu.cn
Purpose: Readmission within a period time of discharge is common and costly. Diabetic patients are at risk of readmission because of comorbidities and complications. It is crucial to monitor patients with diabetes with risk factors for readmission and provide them with target suggestions. We aim to develop a nomogram to predict the risk of readmission within 90 days of discharge in diabetic patients.
Patients and Methods: This is a prospective observational survey. A total of 784 adult patients with diabetes recruited in two tertiary hospitals in central China were randomly assigned to a training set or a validation set at a ratio of 7:3. Depression, anxiety, self-care, physical activity, and sedentary behavior were assessed during hospitalization. A 90-day follow-up was conducted after discharge. Multivariate logistic regression was employed to develop a nomogram, which was validated with the use of a validation set. The AUC, calibration plot, and clinical decision curve were used to assess the discrimination, calibration, and clinical usefulness of the nomogram, respectively.
Results: In this study, the 90-day readmission rate in our study population was 18.6%. Predictors in the final nomogram were previous admissions within 1 year of the index admission, self-care scores, anxiety scores, physical activity, and complicating with lower extremity vasculopathy. The AUC values of the predictive model and the validation set were 0.905 (95% CI=0.874– 0.936) and 0.882 (95% CI=0.816– 0.947). Hosmer–Lemeshow test values were p = 0.604 and p = 0.308 (both > 0.05). Calibration curves showed significant agreement between the nomogram model and actual observations. Decision curve analysis indicated that the nomogram improved the clinical net benefit within a probability threshold of 0.02– 0.96.
Conclusion: The nomogram constructed in this study was a convenient tool to evaluate the risk of 90-day readmission in patients with diabetes and contributed to clinicians screening the high-risk populations.
Keywords: readmission, rehospitalization, diabetes, nomogram, prediction model, diabetes mellitus